Found 2,082 results
By Alex Benfield On December 8, 202104:00 PM Eastern
BTC has seemingly stabilized but is stuck in neutral. In an interesting trend flip, ETH and select altcoins are showing surprising strength anyway.
By Sam Blumenfeld On November 24, 202104:00 PM Eastern
The crypto market continues to tread water and consolidate before an expected late-market cycle push.
By Sam Blumenfeld On November 19, 202104:00 PM Eastern
Bitcoin’s market dominance has slipped again. And while it isn’t typical for Bitcoin to lag the alts at this stage, all major signs still point to a strong push at the end of this market cycle.
By Tony Sagami On November 19, 202107:00 AM Eastern
In 2000, PalmPilot was valued at $53 billion — higher than Apple, Google and Amazon combined.
By Alex Benfield On November 17, 202104:00 PM Eastern
Over the course of the past week, we’ve seen a slight pullback in Bitcoin and the crypto market as a whole. But let’s zoom out and take a look at the macro picture.
By Jon D. Markman On November 17, 202103:00 PM Eastern
Wearing tech hardware to access an alternative digital reality may seem silly and unnecessary, yet it’s going to be a huge new investment opportunity.
By Sam Blumenfeld On November 12, 202103:56 PM Eastern
• Bitcoin (BTC, Tech/Adoption Grade “A-”) is down 3% today, trading around $64,000. • Ethereum (ETH, Tech/Adoption Grade “A”) is also down 3%, sitting close to $4,600. • Bitcoin’s crypto...
By Jurica Dujmovic On November 11, 202105:50 PM Eastern
Yet another week in crypto is behind us, and what a week it was! Plenty of things going on in the industry, as well as on the fringes. Let’s start on the outside and work our way in. First,...
By Jon D. Markman On November 10, 202103:00 PM Eastern
Environmental, social and governance (ESG) investing is one of the biggest investment trends that most investors still don’t fully understand. But it’s going to shape investing for the coming decades,
By Jon D. Markman On November 8, 202102:39 PM Eastern
On Friday, executives at Alphabet (Nasdaq: GOOGL) announced that the company is setting up Isomorphic Labs, a commercial venture that will use artificial intelligence (AI) to develop drug therapies.